{
  "docId": "019de516-9989-7672-a652-fe437099830c",
  "docSlug": "dc4b6dd31d750eecf6a392f7e2ae4db2",
  "documentTitle": "MaxCyte | Investor Presentation Deck | 22 slides",
  "authorId": "maxcyte",
  "authorName": "MaxCyte",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 22,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "solution",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 8,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de516-9989-7672-a652-fe437099830c/3",
  "deckHref": "/decks/019de516-9989-7672-a652-fe437099830c",
  "deckJsonHref": "/decks/019de516-9989-7672-a652-fe437099830c.json",
  "deckAnchorHref": "/decks/019de516-9989-7672-a652-fe437099830c#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.04,
        "w": 0.149,
        "x": 0.808,
        "y": 0.056
      },
      "kind": "image",
      "text": "MaxCyte",
      "attrs": {},
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "36cf03b6-9d63-4b41-aec0-81a6631df013",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.14,
        "w": 0.28,
        "x": 0.34,
        "y": 0.21
      },
      "kind": "list",
      "text": "Leading the growing next-generation cell therapy market and capitalizing on rising demand for non-viral engineering approaches",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "24c7245c-5710-40a5-8bba-b964a84a9a9e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.29,
        "w": 0.29,
        "x": 0.67,
        "y": 0.47
      },
      "kind": "list",
      "text": "Allows MaxCyte to participate in the value created by our partners' programs\n23 SPL partnerships, which include approximately $2B in potential pre-commercial milestone payments with upside from commercial sales-based payments\nFocused over the long-term on creating a diverse portfolio of patient treatments for indications developed by our strategic partners",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "344d13f3-583c-4fe8-b7c4-6f239f9a3589",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.37,
        "w": 0.28,
        "x": 0.35,
        "y": 0.47
      },
      "kind": "list",
      "text": "20+ years of cell engineering expertise; 30+ field sales and application scientists that support our customers*\nSignificant number of collaborations with industry and academia\nFDA Master File and International Technical Files provide clear regulatory path, potentially reducing clinical risk/shortening clinical development\nUsed to manufacture drug products for over 45 clinical trials to date",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "402b8501-6083-4b52-81f8-f62bc80562f8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.14,
        "w": 0.28,
        "x": 0.02,
        "y": 0.21
      },
      "kind": "list",
      "text": "With 600+ platforms in place, our proprietary technology unlocks the significant potential of advanced therapeutics",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7b8f0edd-2805-4d9e-821f-1d765d1c0928",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.11,
        "w": 0.28,
        "x": 0.66,
        "y": 0.21
      },
      "kind": "list",
      "text": "Innovative business model focused on value creation and shared partnership success",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aa9855de-2bb1-40dc-a4b3-895019b220f7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.34,
        "w": 0.27,
        "x": 0.03,
        "y": 0.47
      },
      "kind": "list",
      "text": "Enables delivery of almost any molecule into almost any cell type\nLeads the industry in performance (measured by consistency, efficiency, viability, flexibility and scale)\nExtensive product portfolio, supported by a robust intellectual property portfolio\n~25% 5-Year CAGR of core revenue growth (2018-2022); pharmaceutical-like gross margins of ~89% (2018-2022)",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f1c17d3e-fb2f-43e4-ae44-43dea6911d5c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.01,
        "w": 0.007,
        "x": 0.49,
        "y": 0.96
      },
      "kind": "other",
      "text": "3",
      "attrs": {},
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d96226f7-5a29-428d-be73-2f161e51eac6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.015,
        "w": 0.119,
        "x": 0.697,
        "y": 0.89
      },
      "kind": "source-note",
      "text": "*As of December 31, 2022",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7df8d6b9-ce8c-44fc-8280-d6827db25256",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.01,
        "w": 0.15,
        "x": 0.82,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "© 2023 MaxCyte, Inc. All Rights Reserved",
      "attrs": {
        "numbered": true
      },
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a68e97a9-b820-423c-9b68-e3877d6cc5f9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.71,
        "x": 0.044,
        "y": 0.06
      },
      "kind": "title",
      "text": "A Leading Provider of Cell-Engineering Platform Technologies",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4cfb74b5-4db0-44c7-a134-2c6a516e9025",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "dc4ba62a-618c-493d-8a4f-34a7b51a1e6f",
      "evidence": "list/bullet: 20+ years of cell engineering expertise",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 3,
      "from": 3,
      "beatId": "a2aa412e-b6df-40dd-bb89-7155c0f2769a",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The solution is introduced on page 3",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}